Clorox EVP granted 42,118 CLX shares
Hyder Chris T reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hyder Chris T reported acquisition or exercise transactions in this Form 4 filing.
Clorox executive Chris T. Hyder received a stock grant that increases his direct holdings. He was awarded 42,118 shares of Clorox common stock on June 17, 2026, as a grant or award valued at $94.97 per share. After this grant, he directly holds 77,087 shares. A related footnote states that these Restricted Stock Units will vest in full on June 17, 2029, three years after the grant date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 42,118 | $94.97 | $4.00M |
Footnotes (1)
- F1. The Restricted Stock Units will vest in full on the third anniversary of the grant date, June 17, 2029.
Key Figures
Key Terms
Restricted Stock Units financial
grant date financial
transaction code financial
direct ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Clorox (CLX) EVP Chris Hyder report in this Form 4?
Is the Chris Hyder Form 4 for CLX a stock purchase or a grant?
What is the vesting schedule for Chris Hyder’s Clorox Restricted Stock Units?
AI-generated analysis. How Rhea-AI works. Not financial advice.